USPTO serial 79426083
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Scientific research in the nature of conducting clinical trials for others in the field of cancer; clinical research in the field of cancer; testing of pharmaceuticals; laboratory testing of pharmaceuticals; medical research; pharmaceutical research consultancy; research and development in the field of pharmaceuticals | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 20, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 19, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 19, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 19, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 30, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 12, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 25, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 25, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 30, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 29, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 29, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 28, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 28, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 22, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 1, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 2, 2025 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Jun 19, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |